Albuterol Can Cause Paradoxical Worsening of Cough
Yes, albuterol can make cough worse through paradoxical bronchoconstriction, and your patient's experience of initial improvement followed by worsening is a recognized pattern that warrants immediate discontinuation of the medication.
Understanding the Phenomenon
Paradoxical bronchoconstriction is a rare but potentially serious adverse effect of albuterol. The FDA drug label explicitly lists bronchospasm (8%) and cough (4%) as adverse reactions to albuterol 1. This occurs when the bronchodilator paradoxically causes airway constriction rather than dilation, leading to increased cough, shortness of breath, wheezing, and respiratory distress.
Key Clinical Evidence
When Albuterol Should NOT Be Used
The ACCP guidelines are unequivocal: In patients with acute or chronic cough not due to asthma, albuterol is not recommended (Grade D recommendation) 2. This is critical—if your patient doesn't have confirmed asthma with bronchospasm, albuterol provides no benefit and may cause harm.
Documented Cases of Paradoxical Response
- A case series documented 126 reports of paradoxical bronchospasm with metered-dose inhalers and 58 reports with nebulized solutions submitted to the FDA between 1974-1988 3
- One case report described a patient who experienced severe bronchospasm within 30 minutes of first albuterol use, which recurred upon rechallenge with nebulized albuterol 4
- Patients who report that albuterol makes their symptoms worse should be suspected of having paradoxical bronchospasm 3
What to Do Now
Immediate Actions:
- Stop albuterol immediately—do not rechallenge
- Assess for active bronchospasm (wheezing, increased work of breathing, oxygen desaturation)
- If bronchospasm is present, provide oxygen and consider ipratropium bromide, which is the recommended agent for cough suppression 2
Diagnostic Clarification:
Your patient's pattern suggests she may not have asthma-related cough. Consider:
- Upper respiratory infection: Albuterol has no efficacy for URI-related cough (Grade D) 2
- Acute bronchitis: While one study showed benefit 5, this contradicts guideline recommendations for non-asthmatic cough
- Chronic bronchitis: Central cough suppressants (codeine, dextromethorphan) are recommended instead (Grade B) 2
Alternative Management
For non-asthmatic cough:
- Ipratropium bromide for cough suppression (Grade A) 2
- Codeine or dextromethorphan for chronic bronchitis (Grade B) 2
- Address underlying cause (postnasal drip, GERD, ACE inhibitor if applicable)
Critical Pitfall to Avoid
The most dangerous mistake is continuing or rechallenging with albuterol when a patient reports worsening symptoms. The initial improvement your patient experienced may have been placebo effect or natural disease course, while the subsequent worsening represents the true drug effect. This is potentially life-threatening—paradoxical bronchospasm can progress to severe respiratory distress 4, 3.
Document this as an adverse drug reaction and ensure albuterol is flagged as an allergy/intolerance in the patient's chart to prevent future administration.